
Comparison of adverse renal events between ranibizumab and aflibercept in patients with diabetic macular oedema: A global network study
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBnbXpoczNWc2RYTmhwQ0p0LVhLMUpUYzVaRUN0anRTZGpZRmpxdEhfVXNRZEo2dkVDcWlweVQyRW5sTTl3d0RJRmtscEZFdVFrSWhIOFNrTGpMVlItTWhZ?oc=5" target="_blank">Comparison of adverse renal events between ranibizumab and aflibercept in patients with diabetic macular oedema: A global network study</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
